As well as Coreutils, the Build 2026 developer conference also saw Microsoft announce WSL containers CLI and API to deploy ...

US president calls Abu-Bilal al-Minuki ‘most active terrorist in the world’ and says he was eliminated in ‘very complex mission’ Donald Trump has said US and Nigerian forces killed the “second in ...

Abu-Bilal al-Minuki, alleged to be the second-in-command of ISIL (ISIS) globally, has been killed in an operation conducted by United States and Nigerian forces, the US and Nigerian presidents said.

Trump says sources tracked al-Minuki's movements Biden administration labelled al-Minuki a 'specially designated global terrorist' U.S. increased drone and troop presence in Nigeria after December ...

AI agents have fundamentally changed the threat model of AI model-based applications. By equipping these models with plugins (also called tools), your agents no longer just generate text; they now ...

Most people spend at least four years studying for their bachelor's degree, but now, some students are fast-tracking that process in just weeks using online colleges. Washington Post national ...

SNC’s site for E-4C work in Dayton, Ohio, has rapidly grown since the company won the competition in 2024. Credit: SNC The future backbone of U.S. nuclear command and control is taking shape in a set ...

Something to look forward to: Microsoft released new Windows 11 Insider Preview builds to the Canary, Dev, and Beta channels this week, bringing multiple new features for developers and power users.

Gen. Stephen Whiting noted the number of personnel at Redstone is expected to grow to nearly 200 by the end of 2026. (Staff Sgt. Kirsten Brandes/U.S. Space Force) U.S. Space Command is operating a ...

AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...

Two new cancer cases have prompted Kyowa Kirin to shutter all clinical studies of its investigational anti-OX40 monoclonal antibody designed to treat inflammatory diseases. The discontinuation will ...